Stock RGEN REPLIGEN CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

News Repligen Corporation

Equities

RGEN

US7599161095

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-20 pm EDT 		5-day change 1st Jan Change
171.8 USD -0.09% Intraday chart for Repligen Corporation +5.17% -4.46%
May. 14 Transcript : Repligen Corporation Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-14-2024 10:30 AM
May. 02 UBS Adjusts Price Target on Repligen to $205 From $225, Maintains Buy Rating MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Repligen : Investor Presentation May 2024 Presentation
PU
Transcript : Repligen Corporation Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-14-2024 10:30 AM
Repligen Corporation to Present at Upcoming May Investor Conferences
AQ
UBS Adjusts Price Target on Repligen to $205 From $225, Maintains Buy Rating
MT
Repligen's Q1 Adjusted Earnings, Revenue Fall
MT
Transcript : Repligen Corporation, Q1 2024 Earnings Call, May 01, 2024
(RGEN) REPLIGEN CORPORATION Sees Fiscal Year 2024 EPS Range $1.42 - $1.49
MT
Repligen: Q1 Earnings Snapshot
AQ
Earnings Flash (RGEN) REPLIGEN CORPORATION Posts Q1 Revenue $151.3M, vs. Street Est of $150.1M
MT
Earnings Flash (RGEN) REPLIGEN CORPORATION Posts Adjusted Q1 EPS $0.28, vs. Street Est of $0.30
MT
Repligen Reports First Quarter 2024 Financial Results
AQ
Repligen Corporation Provides Earnings Guidance for the Fiscal Year 2024
CI
Repligen Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
North American Morning Briefing : Traders Wait for -2-
DJ
Repligen to Report First Quarter 2024 Financial Results
AQ
RBC Cuts Price Target on Repligen to $221 From $225, Keeps Outperform Rating
MT
Repligen : Investor Presentation April 2024 Presentations
PU
Transcript : Repligen Corporation Presents at KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum, Mar-20-2024 03:00 PM
Repligen Appoints Maggie A. Pax to Board of Directors
AQ
Repligen Corporation Appoints Maggie A. Pax as Board of Directors
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RGEN Stock
  4. News Repligen Corporation
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW